CD11b+CD14+ BMMNCs improved hepatic fibrosis by reducing oxidative stress and inflammation in mouse models.[599] One clinical trial reported that injection of BMMNCs via the portal vein in decompensated hepatic fibrosis patients, but no significant efficacy was observed (NCT01120925). The gene discussed is CD14; the disease is Hepatic fibrosis.